CTX LifeSciences Pvt. Ltd.

About CTX LifeSciences Pvt. Ltd.

CTX Lifesciences is well reputed player in API & Advance Intermediate manufacturing at Global scale. CTX Lifesciences is vertically an integrated API and intermediate manufacturing company supplying its products across 87 countries. 
It is a Family-Owned Business which was established in the year of 2004 in Surat, India & part of a diverse Chemical Group with more than 65 years in the Chemical Industry. The Facility is having over 1000 KL reaction volume and is spread across 38 acres land which is USFDA approved , EUGMP compliant, Health Canada Inspected, Brazil ANVISA , RUGMP, KFDA, COFEPRIS & Iran MOH certified. The facility is having excellent EHS management capabilities with ISO 14001 & 45001 Certification. It is also Ecovadis Rated & Pharmaceutical Supply Chain Initiative (PSCI) Audited.

CTX also offers Contract development and manufacturing organization (CDMO) services to various customer for Active Pharmaceutical Ingredients (API), Advance Intermediates, Regulatory Starting Material (RSM) and Even Key Starting Material (KSM) Manufacturing. 

The site offers various range of chemical reactions across various scales from Kilo scale to multi-Tonne. The company has pilot scale for new product development, trials and NCE filing. The key reaction consists of Chloro-Sulfonation, Cyanation, Azide Chemistry, Halogenation. CTX also carries out Enzymatic and Chiral Chemistry at our plant. 


Certifications
  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from CTX LifeSciences Pvt. Ltd. (27)

  • Hydrochlorothiazide

    Product Hydrochlorothiazide

    Hydrochlorothiazide is a benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxidesubstituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. It has a role as a xenobiotic, ...
  • Oxcarbazepine

    Product Oxcarbazepine

    Oxcarbazepine is a keto analogue of Carbamazepine and, like the parent drug, is a potent anticonvulsant used alone or in combination with other agents in the therapy of poartial seizures. Oxcarbazepine is a dibenzazepine carboxamide derivative with an anticonvulsant property. As a prodrug, oxcarbazepi...
  • Metoprolol Succinate

    Product Metoprolol Succinate

    Metoprolol Succinate is the succinate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol succinate antagonizes beta 1-adrenergic receptors in the myocardium, thereby ...
  • Rosuvastatin Calcium

    Product Rosuvastatin Calcium

    Rosuvastatin Calcium is the calcium salt form of rosuvastatin, a statin with antilipidemic activity. Rosuvastatin selectively and competitively binds to and inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG...
  • Eslicarbazepine acetate

    Product Eslicarbazepine acetate

    Eslicarbazepine acetate is the acetate ester, with S configuration, of licarbazepine. An anticonvulsant, it is approved for use in Europe and the United States as an adjunctive therapy for epilepsy. It has a role as an anticonvulsant. It is an acetate ester, a dibenzoazepine, a carboxamide and a ...
  • Deferasirox

    Product Deferasirox

    Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to&...
  • 4-Amino-6-chlorobenzene-1,3-disulfonamide (CADS)

    Product 4-Amino-6-chlorobenzene-1,3-disulfonamide (CADS)

    CTX offers a wide range of intermediates which includes 5-chloroaniline-2,4-disulfonamide (CADS). API- Hydrochlorothiazide. Contact us for more information.
  • Acetazolamide

    Product Acetazolamide

    Acetazolamide is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. Acetazolamide is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents e...
  • Amiodarone Hydrochloride

    Product Amiodarone Hydrochloride

    Amiodarone Hydrochloride is the hydrochloride salt of an iodine-rich benzofuran derivative with antiarrhythmic and vasodilatory activities. As a class III antiarrhythmic agent, amiodarone blocks the myocardial calcium, potassium and sodium channels in cardi...
  • Carbamazepine

    Product Carbamazepine

    Carbamazepine is a tricyclic compound chemically related to tricyclic antidepressants (TCA) with anticonvulsant and analgesic properties. Carbamazepine exerts its anticonvulsant activity by reducing polysynaptic responses and blocking post-tetanic potentiation. Its analgesic activity is not understood; how...
  • Carvedilol

    Product Carvedilol

    Carvedilol is a synthetic antihypertensive methoxyphenoxy- 2-propanol derivative with no intrinsic sympathomimetic activity, Carvedilol acts as a nonselective beta-adrenoceptor blocking agent (S(-) enantiomer) and as an alpha 1-adrenoceptor blocker (R(+) and S(-) enantiomers). Its acts more strongly on bet...
  • Chlorothiazide

    Product Chlorothiazide

    Chlorothiazide is a short-acting, benzothiadiazinesulfonamide derivative and prototypical thiazide diuretic. Chlorothiazide is excreted unchanged by the kidneys.

CTX LifeSciences Pvt. Ltd. Resources (1)

  • Video CTX Lifesciences - Your Preferred API, Intermediates Manufacturing & CDMO Partner from India.

    CTX Lifesciences, a vertically integrated Active Pharmaceutical Ingredient (API ) and intermediates manufacturing company supplying & exporting its products across 87 countries. It was established in the year of 2004 in Surat, India and is a part of family owned $600 Million group. This Facility is having over 1000 KL reaction volume and is spread across 38 acres land with sufficient area for expansion. The Active Pharmaceutical Ingredient (API ) products manufactured are backward integrated into intermediates and Key Starting Materials( KSM ), allowing better controls on quality of the products and supply reliability for our customers. This facility is compliant and approved by USFDA, EUGMP, Health Canada, ANVISA, RUGMP, KFDA, COFEPRIS & Iran MOH. The facility is having excellent EHS Management capabilities and certified with ISO 14001:2015 , ISO 45001:2018. This facility is also Ecovadis Rated and Pharmaceutical Supply Chain Initiative ( PSCI ) Audited. Driven...